Bupropion Hydrochloride
Product Images NDC 70934-791

2 FDA label images from Denton Pharma, Inc. Dba Northwind Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 70934-791). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (70934 791 96 Master Bottle Label Approval Rev A 09 20)

Label (70934 791 96 Master Bottle Label Approval   Rev A 09 20)
Label for Bupropion Hydrochloride SR Extended-Release Tablets USP (SR) 150 mg, containing 180 tablets. The label indicates prescription use only, dosing instructions to refer to the package insert, storage conditions between 20°-25°C (68°-77°F), and a caution to keep out of reach of children. The product is labeled with the NDC 70934-791-96 and manufactured by Denton Pharma, Inc. dba Northwind Pharmaceuticals.*
FDA Label Image

Chemical Structure (Bupropion Hydrochloride Sr 1)

Chemical Structure (Bupropion Hydrochloride Sr 1)
Chemical structure of Bupropion Hydrochloride, showing aromatic ring with chlorine substituent and side chains including tert-butyl and ketone groups, alongside the hydrochloride component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.